Research Article
Concomitant Interstitial Lung Disease with Psoriasis
| | | Overall n = 21 median (range) n (%) |
| | Demographic | | | Age (years) | 66 (46, 86) | | Male | 14 (66.7) | | Clinical | | | Body mass index (kg/m2) | 28.9 (20.8, 34.5) | | Smoking | 15 (71.4) | | Home oxygen therapy | 5 (23.8) | | Time from diagnosis of ILD (months) | 27 (0, 36) | | Time from diagnosis of psoriasis (years) | 2 (1, 45) | | Family history of psoriasis | 1 (4.8) | | PH or possible PH | 9 (42.9) | | Gastroesophageal reflux | 10 (47.6) | | NYHA functional class I/II/III/IV | 5/14/2/0 | | Pulmonary function test, % predicted | | | FVC | 69 (38, 89) | | FEV1.0/FVC | 80 (71, 104) | | DLco | 47 (17, 95) | | FEV1.0 | 73 (42, 95) | | 6-minute walking test (m) | 280 (104, 579) | | Lung biopsy | 5 (23.8) |
|
|
ILD: interstitial lung disease; NYHA: New York Heart Association; PH: pulmonary hypertension.
|
